[Dexamethasone-isonicotinic acid ester in the local management of bronchial asthma. Directional clinical-therapeutic evaluation in a blind study].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000627:therapeutic use*; D004304:Dosage Forms; D004357:Drug Synergism; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged
D004304:Dosage Forms; D007539:Isonicotinic Acids; D009921:Metaproterenol; D003907:Dexamethasone; D004809:Ephedrine; D007545:Isoproterenol
Dexamethason-isonicotinsäureester in der Lokalbehandlung des Bronchialasthmas. Orientierende klinisch-therapeutische Prüfung im Blindversuch.